Drugs / Asoprisnil
Trials 15 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 29 trials | ||||||
| Phase 2 | NCT00150644 | Jul 2003 → May 2005 | leiomyoma, uterine benign neoplasm | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00160420 | Dec 2002 → Jul 2004 | endometriosis | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00160433 | Aug 2002 → Jun 2003 | endometriosis | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00288691 | Nov 2001 → Jan 2004 | menstrual disorder | Bayer | Completed | No outcome recorded |
| Phase 2 | NCT00156182 | Apr → Dec 2001 | leiomyoma | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00152295 | Apr → Dec 2001 | — | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00152282 | Sep 2000 → Aug 2001 | amenorrhea | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00160446 | May 2000 → Jul 2001 | endometriosis | Abbott | Completed | No outcome recorded |
| Phase 2 | NCT00160459 | May 2000 → Jul 2001 | leiomyoma | Abbott | Completed | No outcome recorded |
| Phase 36 trials | ||||||
| Phase 3 | NCT00156156 | Nov 2004 → Feb 2007 | hemometra, leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT00156208 | Apr 2004 → Dec 2006 | leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT00156195 | Sep 2003 → Jan 2007 | hemometra, leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT00152256 | Sep 2003 → Feb 2005 | hemometra, leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT00160381 | Sep 2002 → Jan 2005 | hemometra, leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT00152269 | Jul 2002 → Jan 2005 | hemometra, leiomyoma, menstrual disorder | Abbott | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Asoprisnil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00160420 ↗ |
| Known as | Asoprisnilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL267431 ↗ |
| Known as | BAY86-5294 | “Asoprisnil (BAY86-5294)” NCT00288691 ↗ |
| Known as | J867 | “A Phase 2, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Asoprisnil (J867) in Patients With Uterine Leiomyomata.” NCT00160459 ↗ |
| Modality | Other / unclassified | “the selective progesterone receptor modulator asoprisnil” PMID 31777761 ↗ Nov 2019 |
| Route | Oral | “Asoprisnil 10mg Tablet, oral Daily for 12 weeks” NCT00150644 ↗ |
| Target | PGR | “a novel selective progesterone receptor modulator” PMID 17307170 ↗ Feb 2007 |